Effect of phenothiazine neuroleptic drugs and tricyclic antidepressants on phosphodiesterase activity in rat cerebral cortex.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000201:enzymology*; D002746:Chlorpromazine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D003984:Dibenzazepines / Q000494:pharmacology; D003986:Dibenzocycloheptenes / Q000494:pharmacology; D005476:Fluphenazine / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D010640:Phenothiazines / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats; D013881:Thioridazine / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D003984:Dibenzazepines; D003986:Dibenzocycloheptenes; D010640:Phenothiazines; D010726:Phosphodiesterase Inhibitors; D014268:Trifluoperazine; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine